tetano
Editor, Senior Moderator
Am J Prev Med. 2014 Jun;46(6):552-8. doi: 10.1016/j.amepre.2014.01.007.
Influenza vaccination coverage among adult survivors of pediatric cancer.
Ojha RP1, Offutt-Powell TN2, Gurney JG3.
Author information
Abstract
BACKGROUND:
A large proportion of long-term survivors of childhood cancer have treatment-related adverse cardiac and pulmonary late-effects, with related mortality. Consequently, this population of approximately 379,000 individuals in the U.S. is at high risk of complications from influenza infections.
PURPOSE:
To estimate influenza vaccination coverage overall and among subgroups of adult survivors of pediatric cancer aged 18-64 years and to compare coverage with the general adult U.S. population.
METHODS:
Data from the 2009 Behavioral Risk Factor Surveillance System were analyzed in 2013 using binomial regression to estimate influenza vaccination coverage differences (CDs) and corresponding 95% confidence limits (CLs) between adult survivors of pediatric cancer and the general U.S. population. Analyses were stratified by demographic characteristics and adjusted for design effects, non-coverage, and non-response.
RESULTS:
Influenza vaccination coverage was 37% for adult pediatric cancer survivors overall and 31% for the general adult U.S. population (CD=6.3%, 95% CL=0.04%, 13%). Dramatically lower coverage was observed for non-Hispanic black survivors (6%) than for non-Hispanic blacks in the general U.S. population (26%; CD=-18%, 95% CL=-25%, -11%).
CONCLUSIONS:
Although influenza vaccination coverage was modestly higher among adult survivors of pediatric cancer than the general U.S. population, coverage was less than desirable for a population with a high prevalence of cardiopulmonary conditions and early mortality, and far lower than the Healthy People 2010 goal of 60% or Healthy People 2020 goal of 80% for the general population.
Copyright ? 2014 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.
PMID:
24842731
[PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/24842731
Influenza vaccination coverage among adult survivors of pediatric cancer.
Ojha RP1, Offutt-Powell TN2, Gurney JG3.
Author information
Abstract
BACKGROUND:
A large proportion of long-term survivors of childhood cancer have treatment-related adverse cardiac and pulmonary late-effects, with related mortality. Consequently, this population of approximately 379,000 individuals in the U.S. is at high risk of complications from influenza infections.
PURPOSE:
To estimate influenza vaccination coverage overall and among subgroups of adult survivors of pediatric cancer aged 18-64 years and to compare coverage with the general adult U.S. population.
METHODS:
Data from the 2009 Behavioral Risk Factor Surveillance System were analyzed in 2013 using binomial regression to estimate influenza vaccination coverage differences (CDs) and corresponding 95% confidence limits (CLs) between adult survivors of pediatric cancer and the general U.S. population. Analyses were stratified by demographic characteristics and adjusted for design effects, non-coverage, and non-response.
RESULTS:
Influenza vaccination coverage was 37% for adult pediatric cancer survivors overall and 31% for the general adult U.S. population (CD=6.3%, 95% CL=0.04%, 13%). Dramatically lower coverage was observed for non-Hispanic black survivors (6%) than for non-Hispanic blacks in the general U.S. population (26%; CD=-18%, 95% CL=-25%, -11%).
CONCLUSIONS:
Although influenza vaccination coverage was modestly higher among adult survivors of pediatric cancer than the general U.S. population, coverage was less than desirable for a population with a high prevalence of cardiopulmonary conditions and early mortality, and far lower than the Healthy People 2010 goal of 60% or Healthy People 2020 goal of 80% for the general population.
Copyright ? 2014 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.
PMID:
24842731
[PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/24842731